Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
>=10.0-<20.0%
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
>=1.0-<10.0%
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
>=1.0-<3.0%
EC/CAS
208-762-8/540-97-6
Name of the chemical
D6
Concentration
>=1.0-<10.0%
EC/CAS
208-764-9/541-02-6
Name of the chemical
D5
Concentration
>=1.0-<10.0%
EC/CAS
200-289-5/56-81-5
Name of the chemical
glycerol
Concentration
>=1.0-<10.0%
General Information
Version
2.0
Revision date
2022-04-07
Product name
MOLYKOTE 3179 Dilatant Compound
1.2.1 Relevant identified uses
Lubricants and lubricant additives
Emergency telephone
+(44)-870-8200418
Icons in SDS
Company Information
company name
SPECIALTY ELECTRONIC MATERIALS UK
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion-EU@dupont.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H350, H372
Hazard statements
Code
Statements
H350
May cause cancer
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
DANGER
Hazard statements
H350 May cause cancer. H372 Causes damage to organs (Lungs) through prolonged or repeated exposure if inhaled.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe mist or vapours. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P501 Dispose of contents/ container to an approved waste disposal plant.
Additional information
EUH211 Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist. The following percentage of the mixture consists of ingredient(s) with unknown acute dermal toxicity: 1.4 % The following percentage of the mixture consists of ingredient(s) with unknown acute inhalation toxicity: 1.5 %
Contains
Quartz
2.3 Other hazards
Endocrine disrupting properties (human health): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Endocrine disrupting properties (environment): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Results of PBT and vPvB assessment
This substance/mixture contains components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB). This product contains octamethylcyclotetrasiloxane (D4) that has been identified by the Member State Committee of ECHA as fulfilling the PBT and vPvB criteria laid down in Annex XIII to Regulation (EC) No
